Home / MSCL.TO : TSX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MSCL.TO make money? Does MSCL.TO have pricing power? What's the Earnings Whisper? Will MSCL.TO profit more as the business scales? What is MSCL.TO's management track record? Is MSCL.TO's current price justified?

Satellos Bioscience Inc.

CAD 13.51 +$5.11 (+60.83%)

TSX · 14 Sep 2026 19:59 UTC

Previous Close

CAD 13.2

Day Range

CAD 13.51CAD 14

Year Range

CAD 7.32CAD 18.98

Market Cap

281.43M

AVG Volume

19.61K

Trailing/Forward PE

-4.9/-

PEG ratio

27.07

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Toronto Stock Exchange

Net Income (USD)

MSCL.TO Net Income (USD) by year
Period	Net Income (USD)
2025	-25M
2024	-28.1M
2023	-15.89M
2022	-10.4M
2021	-14.43M
2020	-1.69M
2019	-1.94M
2018	-1.7M
2017	-1.24M

Operating Income (USD)

MSCL.TO Operating Income (USD) by year
Period	Operating Income (USD)
2025	-26.58M
2024	-27.81M
2023	-15.46M
2022	-7.97M
2021	-4.37M
2020	-2.34M
2019	-2.21M
2018	-2.2M
2017	-1.47M

EBITDA (USD)

MSCL.TO EBITDA (USD) by year
Period	EBITDA (USD)
2025	-26.65M
2024	-28.08M
2023	-15.71M
2022	-7.15M
2021	-3.56M
2020	-1.98M
2019	-2.2M
2018	-2.2M
2017	-1.27M

Cash Flows (USD)

MSCL.TO Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-23.72M
2024	-24.98M
2023	-14.52M
2022	-5.65M
2021	-4.58M
2020	-1.66M
2019	-1.21M
2018	-121.36K

EPS (USD)

MSCL.TO EPS (USD) by year
Period	EPS (USD)
2025	-1.73
2024	-2.78
2023	-2.19
2022	-2.21
2021	-4.17
2020	-3.91
2019	-3.76
2018	-5.56
2017	-0.85

Expenses (USD)

MSCL.TO Expenses (USD) by year
Period	Expenses (USD)
2025	23.42M
2024	27.47M
2023	15.38M
2022	7.04M
2021	3.59M
2020	2.01M
2019	1.17M
2018	1.95M
2017	1.45M

Cash & Debt (USD)

MSCL.TO Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	27.66M
2024	69.85M
2023	39.59M
2022	1.92M
2021	7.23M
2020	717.7K
2019	990.42K
2018	10.14K
2017	1.13M

Debt ratios

MSCL.TO Debt ratios by year
Period	Debt ratios
2025	0.36
2024	1.28
2023	1.39
2022	0.13
2021	0.73
2020	-0.05

Return on Capital

MSCL.TO Return on Capital by year
Period	Return on Capital
2025	-90.15%
2024	-41.41%
2023	-39.07%
2022	-308.65%
2021	-175.59%
2020	918.26%
2019	-293.17%
2018	272.6%
2017	-113.82%

Shares Outstanding

MSCL.TO Shares Outstanding by year
Period	Shares Outstanding
2025	15.46M
2024	13.82M
2023	9.4M
2022	3.48M
2021	33.23M
2020	18.08M
2019	640.62K
2018	351.91K
2017	351.91K

Book Value Per Share (USD)

MSCL.TO Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	1.79
2024	4.91
2023	4.33
2022	0.97
2021	0.25
2020	-0.01
2019	1.03
2018	-1.77
2017	3.09

Total Assets (USD)

MSCL.TO Total Assets (USD) by year
Period	Total Assets (USD)
2025	31.83M
2024	73.02M
2023	44.3M
2022	6.2M
2021	9.87M
2020	1.13M
2019	1.47M
2018	178.14K
2017	1.37M

Free Cash Flow Yield

MSCL.TO Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-14.36%
Sep 26	-14.69%
Sep 26	-15.54%
Aug 26	-16.05%
Aug 26	-14.25%
Aug 26	-14.5%
Aug 26	-14.2%
Jul 26	-14%
Jul 26	-14.13%
Jul 26	-15.95%
Jul 26	-14.63%
Jul 26	-18.21%
Jun 26	-21.34%
Jun 26	-26.63%
Jun 26	-26.76%
Jun 26	-26.08%
May 26	-20.94%
May 26	-22.19%
May 26	-21.19%
May 26	-20.45%
May 26	-19.63%
Apr 26	-21.5%
Apr 26	-17.63%
Apr 26	-23.46%
Apr 26	-25.88%
Mar 26	-27.94%
Mar 26	-23.47%
Mar 26	-21.64%
Mar 26	-14.49%
Feb 26	-13.88%
Feb 26	-15.19%
Feb 26	-14.98%
Feb 26	-14.75%
Jan 26	-15.24%
Jan 26	-17.19%
Jan 26	-21.82%
Jan 26	-24.04%
Jan 26	-28.3%
Dec 25	-29.07%
Dec 25	-28.91%
Dec 25	-29.28%
Dec 25	-29.38%
Nov 25	-28.04%
Nov 25	-29.11%
Nov 25	-27.36%
Nov 25	-29%
Oct 25	-25.91%
Oct 25	-27.69%
Oct 25	-24.96%
Oct 25	-24.93%
Oct 25	-24.83%
Sep 25	-32.11%
Sep 25	-33.24%
Sep 25	-31.42%
Sep 25	-31.85%
Aug 25	-34.81%
Aug 25	-35.62%
Aug 25	-35.6%
Aug 25	-36.69%
Aug 25	-38.11%
Jul 25	-37.19%
Jul 25	-35.35%
Jul 25	-35.87%
Jul 25	-33.89%
Jun 25	-25.97%
Jun 25	-27.39%
Jun 25	-27.9%
Jun 25	-26.43%
May 25	-23.18%
May 25	-19.82%
May 25	-23.91%
May 25	-22.83%
May 25	-22.83%
Apr 25	-23.91%
Apr 25	-23.54%
Apr 25	-23.91%
Apr 25	-23.18%
Mar 25	-25.01%
Mar 25	-25.98%
Mar 25	-21.74%
Mar 25	-23.81%
Feb 25	-22.73%
Feb 25	-25.65%
Feb 25	-27.4%
Feb 25	-25.32%
Jan 25	-24.1%
Jan 25	-22.99%
Jan 25	-24.4%
Jan 25	-23.53%
Jan 25	-22.73%
Dec 24	-22.41%
Dec 24	-23.2%
Dec 24	-20.33%
Dec 24	-24.34%
Nov 24	-28.17%
Nov 24	-26.29%
Nov 24	-23.2%
Nov 24	-23.2%
Nov 24	-23.76%
Oct 24	-24.34%

Price to Book

MSCL.TO Price to Book by year
Period	Price to Book
Sep 26	2.54
Sep 26	2.48
Sep 26	2.35
Aug 26	2.27
Aug 26	2.56
Aug 26	2.51
Aug 26	2.57
Jul 26	2.6
Jul 26	2.58
Jul 26	2.29
Jul 26	2.49
Jul 26	2
Jun 26	4.01
Jun 26	3.21
Jun 26	3.2
Jun 26	3.28
May 26	4.08
May 26	3.85
May 26	4.04
May 26	4.18
May 26	4.36
Apr 26	3.98
Apr 26	4.85
Apr 26	3.65
Apr 26	3.3
Mar 26	2.54
Mar 26	3.03
Mar 26	3.28
Mar 26	4.9
Feb 26	5.12
Feb 26	4.68
Feb 26	4.74
Feb 26	4.82
Jan 26	4.66
Jan 26	4.13
Jan 26	3.25
Jan 26	2.95
Jan 26	2.51
Dec 25	2.19
Dec 25	2.2
Dec 25	2.17
Dec 25	2.17
Nov 25	2.27
Nov 25	2.19
Nov 25	2.33
Nov 25	2.19
Oct 25	2.46
Oct 25	2.3
Oct 25	2.55
Oct 25	2.55
Oct 25	2.56
Sep 25	1.88
Sep 25	1.82
Sep 25	1.93
Sep 25	1.9
Aug 25	1.74
Aug 25	1.7
Aug 25	1.7
Aug 25	1.65
Aug 25	1.59
Jul 25	1.63
Jul 25	1.71
Jul 25	1.69
Jul 25	1.79
Jun 25	1.42
Jun 25	1.34
Jun 25	1.32
Jun 25	1.39
May 25	1.59
May 25	1.86
May 25	1.54
May 25	1.61
May 25	1.61
Apr 25	1.54
Apr 25	1.56
Apr 25	1.54
Apr 25	1.59
Mar 25	4.39
Mar 25	4.23
Mar 25	5.05
Mar 25	4.61
Feb 25	4.83
Feb 25	4.28
Feb 25	4.01
Feb 25	4.34
Jan 25	4.56
Jan 25	4.78
Jan 25	4.5
Jan 25	4.67
Jan 25	4.83
Dec 24	3.4
Dec 24	3.29
Dec 24	3.75
Dec 24	3.13
Nov 24	2.71
Nov 24	2.9
Nov 24	3.29
Nov 24	3.29
Nov 24	3.21
Oct 24	3.13

No video analysis for this stock yet. Request one from our team.

News: MSCL.TO

globenewswire.com · 17 Jun 2026

Satellos Bioscience Announces Results of Annual Meeting of Shareholders

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, announced today the results of its Annual Meeting of Shareholders held June 17, 2026 (the "Meeting").

AI Analysis

Satellos Bioscience Inc.

Video analysis: MSCL.TO

News: MSCL.TO

Satellos Bioscience Announces Results of Annual Meeting of Shareholders

Similar companies